Tool Comparison
InvestorGain vs IPOScoop
- Paid from
- —
- Free plan
- Yes
- Platforms
- Web, Mobile
Best if
- Delayed quotes won't cut it; you need real-time data
- You do a lot of your research from your phone
- You want new issues & calendars, blogs, and education.
- Paid from
- On request
- Free plan
- Yes
- Platforms
- Web
Best if
- You want news, scores, and regulatory filings monitoring.
Pick InvestorGain if
InvestorGain
Free · Web · Mobile
- Delayed quotes won't cut it; you need real-time data
- You do a lot of your research from your phone
- You want new issues & calendars, blogs, and education.
Pick IPOScoop if
IPOScoop
Free • Contact for pricing · Web
- You want news, scores, and regulatory filings monitoring.
Skip both if: Neither one clicks with how you research; there are strong third options.
See alternativesOther tools you might like
Outbound links may include affiliate or sponsor codes.
Not set on either one? See the top 50 tools, ranked by user votes, or the deals page for big discounts on popular tools.
Our take
The bottom line
InvestorGain and IPOScoop cover a lot of the same ground (3 shared categories, IPO, corporate actions & special situations, and calendar), so for the basics you won't go far wrong with either. InvestorGain includes new issues & calendars and blogs, and IPOScoop includes news and scores.
What readers say
InvestorGain
No votes yet. Cast the first one.
IPOScoop
No votes yet. Cast the first one.
Key differences at a glance
- Real-time data
- InvestorGain
- Free trial
- IPOScoop30 days
- Mobile app
- InvestorGain
- Global coverage
- InvestorGain
- Asset coverage
- InvestorGainAdds bonds
- Free plan
- Both
What InvestorGain does best
- Track mainboard and SME IPO GMP, estimated listing price, Kostak rates, and GMP compared with actual listing performance.
- Monitor IPO subscription status with retail, NII, QIB, and total bid multiples.
- IPO calendars, allotment status pages, listing timelines, issue price bands, lot sizes, and post-listing outcomes from one public web/mobile portal.
- Review anchor investor allocation reports by year for mainboard and SME IPOs.
- Compare issue price, listing price, listing gain, and later performance with the earlier GMP estimate.
What IPOScoop does best
- Tracking upcoming and recently priced U.S.
- Direct access to IPO profiles with ticker, exchange, share count, price range, underwriters, historical notes, and selected deal details.
- SCOOP Ratings as a subscriber feature for a 1-to-5-star view of expected opening-day premium sentiment.
- Review quiet-period and lock-up expiration trackers when post-IPO analyst coverage windows or insider-sale windows matter.
- Monitor IPOs Recently Filed, IPOs by Managers, and IPOs by Industry to understand the deal pipeline.
Side by side
Pricing comparison
See for yourself
Side by side
Price, platforms, data, and market coverage.ShowHide
Side by side
| Attribute | ||
|---|---|---|
| Pricing & plans | ||
Starting price | Free | Free • Contact for pricing |
Free tier | Yes | Yes |
Free trial | — | 30 days |
| Platforms & access | ||
Web app | Yes | Yes |
Mobile app | Yes | No |
API access | No | No |
Broker sync | No | — |
| Audience & fit | ||
Experience level | Beginner, Intermediate, Advanced | Beginner, Intermediate, Advanced |
Best for | — | — |
Categories covered | 6 | 6 |
Regions | APAC | North America |
| Data & capabilities | ||
Data quality | 4 signals: Latency: Real-time and End of Day, Granularity: Minute and EOD +2 more | — |
| Try it | Visit InvestorGain | Visit IPOScoop |
Standout features
The best features of InvestorGain and IPOScoop.ShowHide
Standout features
What InvestorGain does best
- Track mainboard and SME IPO GMP, estimated listing price, Kostak rates, and GMP compared with actual listing performance.
- Monitor IPO subscription status with retail, NII, QIB, and total bid multiples.
- IPO calendars, allotment status pages, listing timelines, issue price bands, lot sizes, and post-listing outcomes from one public web/mobile portal.
- Review anchor investor allocation reports by year for mainboard and SME IPOs.
- Compare issue price, listing price, listing gain, and later performance with the earlier GMP estimate.
What IPOScoop does best
- Tracking upcoming and recently priced U.S.
- Direct access to IPO profiles with ticker, exchange, share count, price range, underwriters, historical notes, and selected deal details.
- SCOOP Ratings as a subscriber feature for a 1-to-5-star view of expected opening-day premium sentiment.
- Review quiet-period and lock-up expiration trackers when post-IPO analyst coverage windows or insider-sale windows matter.
- Monitor IPOs Recently Filed, IPOs by Managers, and IPOs by Industry to understand the deal pipeline.
All details
Every attribute we track for InvestorGain and IPOScoop.ShowHide
All details
| Attribute | ||
|---|---|---|
| Coverage & fit | ||
Asset types | StocksBonds | Stocks |
Experience | BeginnerIntermediateAdvanced | BeginnerIntermediateAdvanced |
Regions | APAC | North America |
Coverage details | Countries: INExchanges: XBOM and XNSEIdentifiers: Ticker | Countries: USExchanges: XNYS, XNAS, and XASEIdentifiers: Ticker |
| Data | ||
Data freshness | Real-timeEnd of Day | Not specified |
Data granularity | MinuteEOD | Not specified |
| Plans & trust | ||
Vendor & support | Primish Infotech Private LimitedCountry: IndiaFounded 2015Support: Email | IPOScoop.com LLCCountry: United StatesSupport: Email and Phone |
Curation ratings | Methodology 3/5Reliability 3/5UX 4/5 | Not specified |
Green tags are exclusive to that tool in this comparison.
Pricing
Plans, billing, free trials, and monthly prices.ShowHide
Pricing
| Tier | ||
|---|---|---|
| Free plan | Free | Free |
| Entry paid plan | — | $19.95/mo“Subscriber (Monthly)” |
| Top plan | — | $199.50/yr“Subscriber (Annual)” |
| Custom / enterprise | — | Contact sales“Corporate XML Feed” |
| Free trial | — | 30 days |
Alternatives
Free alternatives
Questions we keep getting
What's the difference between InvestorGain and IPOScoop?
InvestorGain leans toward IPO, corporate actions & special situations, and new issues & calendars, while IPOScoop puts more weight on IPO, corporate actions & special situations, and calendar. They overlap in 3 categories, so for most people it comes down to workflow preference and price.
How much do InvestorGain and IPOScoop cost?
Good news: both InvestorGain and IPOScoop have free plans, so you can run them side by side and only pay if you hit a wall.
Can I use InvestorGain or IPOScoop on my phone?
InvestorGain lists a dedicated mobile app, so it travels better. IPOScoop doesn't list a dedicated mobile app; its documented access is web.
Should I choose InvestorGain or IPOScoop?
It depends on what you're after. Pick InvestorGain if new issues & calendars and blogs matter to you; go with IPOScoop if you'd rather have news and scores. And if you only need the basics both share, let price decide.
What asset classes do InvestorGain and IPOScoop cover?
Both cover stocks. InvestorGain also handles bonds.
Does InvestorGain or IPOScoop have real-time data?
InvestorGain offers real-time data, which matters if you trade actively. IPOScoop runs on delayed or end-of-day data, which is perfectly fine for longer-term investors who don't live and die by the tick.
Which covers international markets: InvestorGain or IPOScoop?
InvestorGain has documented international coverage (APAC), so it's the safer bet if you hold non-US stocks. IPOScoop is more region-specific, mainly North America.
Keep researching
Other tools you might like
Keep Exploring
Feedback
Spot stale pricing, missing features, or a comparison that feels off? Send feedback on the verdict, table, alternatives, or recommendation.
Curation & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.